Skip to content

Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04490772
Enrollment
200
Registered
2020-07-29
Start date
2020-07-31
Completion date
2020-09-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious

Keywords

Covid-19, characteristics, Outcome, Egypt

Brief summary

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.

Detailed description

Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients: Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation. Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin. Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.

Interventions

DIAGNOSTIC_TESTLaboratory tests

Laboratory tests such as CBC, Liver function and CRP

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Confirmed Covid-19 with GIT manifestations

Exclusion criteria

* Patients refuse to participate

Design outcomes

Primary

MeasureTime frameDescription
Clinical data questionnaire2 monthsClinical characteristics of age, sex, comorbidities and symptoms.
Tests such as CBC2 monthsLaboratory characters
liver function test2 monthsLaboratory characters

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026